CYDX Stock Overview
A healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CYduct Diagnostics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.30 |
| 52 Week High | US$0.60 |
| 52 Week Low | US$0.30 |
| Beta | 0 |
| 1 Month Change | -12.86% |
| 3 Month Change | 1.67% |
| 1 Year Change | -32.24% |
| 3 Year Change | 335.09% |
| 5 Year Change | -28.24% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CYDX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 1.2% |
| 1Y | -32.2% | -1.0% | 20.6% |
Return vs Industry: CYDX underperformed the US Medical Equipment industry which returned -1% over the past year.
Return vs Market: CYDX underperformed the US Market which returned 20.6% over the past year.
Price Volatility
| CYDX volatility | |
|---|---|
| CYDX Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CYDX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CYDX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Dom Gatto | cyductdx.com |
CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company’s products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation.
CYduct Diagnostics, Inc. Fundamentals Summary
| CYDX fundamental statistics | |
|---|---|
| Market cap | US$1.60m |
| Earnings (TTM) | US$136.51k |
| Revenue (TTM) | US$344.78k |
0.0x
P/E Ratio0.0x
P/S RatioIs CYDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CYDX income statement (TTM) | |
|---|---|
| Revenue | US$344.78k |
| Cost of Revenue | US$134.68k |
| Gross Profit | US$210.11k |
| Other Expenses | US$73.60k |
| Earnings | US$136.51k |
Last Reported Earnings
Mar 31, 2012
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CYDX perform over the long term?
See historical performance and comparison